MA48621A - Procédé de préparation d'une formulation de poudre sèche contenant un anticholinergique, un corticostéroïde et un bêta-adrénergique - Google Patents
Procédé de préparation d'une formulation de poudre sèche contenant un anticholinergique, un corticostéroïde et un bêta-adrénergiqueInfo
- Publication number
- MA48621A MA48621A MA048621A MA48621A MA48621A MA 48621 A MA48621 A MA 48621A MA 048621 A MA048621 A MA 048621A MA 48621 A MA48621 A MA 48621A MA 48621 A MA48621 A MA 48621A
- Authority
- MA
- Morocco
- Prior art keywords
- anticholinergic
- corticosteroid
- adrenergic
- beta
- preparing
- Prior art date
Links
- 230000001078 anti-cholinergic effect Effects 0.000 title 1
- 239000003246 corticosteroid Substances 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Otolaryngology (AREA)
- Pain & Pain Management (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17170657 | 2017-05-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA48621A true MA48621A (fr) | 2021-04-28 |
Family
ID=58707349
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA048621A MA48621A (fr) | 2017-05-11 | 2018-05-09 | Procédé de préparation d'une formulation de poudre sèche contenant un anticholinergique, un corticostéroïde et un bêta-adrénergique |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US10786450B2 (fr) |
| EP (1) | EP3621590B1 (fr) |
| KR (3) | KR102637303B1 (fr) |
| CN (1) | CN110582269B (fr) |
| CA (1) | CA3060020A1 (fr) |
| ES (1) | ES2891346T3 (fr) |
| MA (1) | MA48621A (fr) |
| MX (1) | MX379783B (fr) |
| PL (1) | PL3621590T3 (fr) |
| RU (1) | RU2742376C1 (fr) |
| WO (1) | WO2018206618A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102898819B1 (ko) * | 2019-09-24 | 2025-12-12 | 키에시 파르마슈티시 엣스. 피. 에이. | 흡입용 건조 분말 제제를 위한 신규 담체 입자 |
| WO2021260441A1 (fr) * | 2020-06-26 | 2021-12-30 | Mylan Pharma Uk Limited | Formulations comprenant du (5-[3-(3-hydroxyphénoxy)azétidin-1-yl]-5-méthyl-2,2-diphénylhexanamide |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20011227A1 (es) | 2000-04-17 | 2002-01-07 | Chiesi Farma Spa | Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros |
| GB0015043D0 (en) | 2000-06-21 | 2000-08-09 | Glaxo Group Ltd | Medicament dispenser |
| PT1386630E (pt) | 2002-07-31 | 2006-09-29 | Chiesi Farma Spa | Inalador em po |
| GB0525254D0 (en) * | 2005-12-12 | 2006-01-18 | Jagotec Ag | Powder compositions for inhalation |
| GB0613161D0 (en) * | 2006-06-30 | 2006-08-09 | Novartis Ag | Organic Compounds |
| TWI495468B (zh) | 2009-12-23 | 2015-08-11 | 吉斯藥品公司 | 治療慢性阻塞性肺病(copd)之醫藥組成物 |
| DK3527199T3 (da) * | 2012-01-25 | 2022-10-24 | Chiesi Farm Spa | Tørpulverformulering omfattende et kortikosteroid og et beta-adrenergikum til indgivelse via inhalation |
| KR102275904B1 (ko) * | 2013-07-11 | 2021-07-13 | 키에시 파르마슈티시 엣스. 피. 에이. | 흡입에 의한 투여를 위한 항콜린제, 코르티코스테로이드 및 베타-아드레날린성 약물을 포함하는 건조 분말 제제 |
| BR112016029487B1 (pt) | 2014-06-30 | 2022-03-29 | Chiesi Farmaceutici S.P.A. | Aba para um mecanismo e inalador de pó |
| LT3620176T (lt) | 2015-11-16 | 2021-11-10 | Chiesi Farmaceutici S.P.A. | Inhaliacinių miltelių kompozicijos, apimančios anticholinerginį agentą, kortikosteroidą ir beta adrenerginį agentą, paruošimo būdas |
| PT3689379T (pt) | 2015-11-16 | 2021-09-24 | Chiesi Farm Spa | Processo para preparar uma formulação de pó seco que compreende um anticolinérgico, um corticoide e um betaadrenérgico |
| MA48620A (fr) * | 2017-05-11 | 2021-04-28 | Chiesi Farm Spa | Procédé de préparation d'une formulation de poudre sèche contenant un anticholinergique, un corticostéroïde et un bêta-adrénergique |
-
2018
- 2018-05-09 EP EP18725443.8A patent/EP3621590B1/fr active Active
- 2018-05-09 US US15/975,146 patent/US10786450B2/en active Active
- 2018-05-09 ES ES18725443T patent/ES2891346T3/es active Active
- 2018-05-09 CN CN201880029982.3A patent/CN110582269B/zh active Active
- 2018-05-09 MA MA048621A patent/MA48621A/fr unknown
- 2018-05-09 KR KR1020197033082A patent/KR102637303B1/ko active Active
- 2018-05-09 MX MX2019012931A patent/MX379783B/es unknown
- 2018-05-09 RU RU2019139869A patent/RU2742376C1/ru active
- 2018-05-09 KR KR1020227038724A patent/KR20220155395A/ko not_active Ceased
- 2018-05-09 CA CA3060020A patent/CA3060020A1/fr active Pending
- 2018-05-09 WO PCT/EP2018/061953 patent/WO2018206618A1/fr not_active Ceased
- 2018-05-09 KR KR1020247021477A patent/KR20240104225A/ko active Pending
- 2018-05-09 PL PL18725443T patent/PL3621590T3/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20190142770A (ko) | 2019-12-27 |
| EP3621590A1 (fr) | 2020-03-18 |
| CN110582269B (zh) | 2023-02-28 |
| BR112019023378A2 (pt) | 2020-06-16 |
| KR20220155395A (ko) | 2022-11-22 |
| US20180325816A1 (en) | 2018-11-15 |
| RU2742376C1 (ru) | 2021-02-05 |
| CN110582269A (zh) | 2019-12-17 |
| KR102637303B1 (ko) | 2024-02-20 |
| KR20240104225A (ko) | 2024-07-04 |
| CA3060020A1 (fr) | 2018-11-15 |
| EP3621590B1 (fr) | 2021-09-01 |
| MX2019012931A (es) | 2020-01-20 |
| PL3621590T3 (pl) | 2022-01-17 |
| US10786450B2 (en) | 2020-09-29 |
| ES2891346T3 (es) | 2022-01-27 |
| MX379783B (es) | 2025-03-04 |
| WO2018206618A1 (fr) | 2018-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA50487A (fr) | Procédé de préparation d'une formulation de poudre sèche contenant un anticholinergique, un corticostéroïde et un bêta-adrénergique | |
| EP3486242A4 (fr) | Dérivé d'oxopicolinamide, son procédé de préparation et son utilisation pharmaceutique | |
| EP3406625A4 (fr) | Poudre d'oligopeptides de noix, et son procédé de préparation et application associée | |
| EP3453707A4 (fr) | Dérivé de benzazépine, procédé pour le préparer, composition pharmaceutique et son utilisation | |
| GEAP201914678A (en) | New hydroxyester derivatives, a process for their preparation and pharmaceutical compositions containing them | |
| SA518400356B1 (ar) | مثبطات الأرجيناز واستخداماتها العلاجية | |
| EP3449956A4 (fr) | Composition d'hydrogel médical, hydrogel médical, leur procédé de préparation et leur application | |
| MA43242A (fr) | Mélange pour traiter des engrais à base d'urée | |
| GEAP201914680A (en) | New hydroxyacid derivatives, a process for their preparation and pharmaceutical compositions containing them | |
| GEAP202014858A (en) | New ammonium derivatives, a process for their preparation and pharmaceutical compositions containing them | |
| EP3407737A4 (fr) | Procédé de préparation de poudre d'arêtes de poisson | |
| MA52253A (fr) | Formulation de poudre nasale pour le traitement de l'hypoglycémie | |
| EP2978423A4 (fr) | Nanocomposition stable comprenant de la doxorubicine, procédé pour la préparation de celle-ci, son utilisation et compositions pharmaceutiques contenant celle-ci | |
| EP3404024A4 (fr) | Dérivé de quinazolinone, son procédé de préparation, composition pharmaceutique, et applications associées | |
| MA52437A (fr) | Une formulation de poudre sèche contenant un anticholinergique, un corticoïde et un bêta-adrénergique | |
| EP3438105A4 (fr) | Composé de diaryl-b-lactame et son procédé de préparation et utilisation pharmaceutique associée | |
| MX2017015370A (es) | Compuestos heterociclicos de 3,3-difluorpiperidina carbamato como antagonistas del receptor de n-metil-d-aspartato (nmda) nr2b. | |
| EP3623503A4 (fr) | Médicament protéique multispécifique et bibliothèque associée, procédé de préparation associé et application associée | |
| MA48621A (fr) | Procédé de préparation d'une formulation de poudre sèche contenant un anticholinergique, un corticostéroïde et un bêta-adrénergique | |
| MA48620A (fr) | Procédé de préparation d'une formulation de poudre sèche contenant un anticholinergique, un corticostéroïde et un bêta-adrénergique | |
| EP3402798A4 (fr) | Composés antagonistes du récepteur a3 de l'adénosine, leur procédé de préparation et leur utilisation médicale | |
| EP3641797A4 (fr) | Procédé de préparation d'une composition normalisee d'arjunoglucoside provenant de l'écorce determinalia arjuna | |
| EP3564219A4 (fr) | Procédé de préparation d'un composé oxadiazacyclo et son utilisation | |
| EP3328435A4 (fr) | Composition pharmaceutique à stabilité au stockage améliorée, et son procédé de préparation | |
| EP3650148A4 (fr) | Procédé de préparation de poudre magnétique et poudre magnétique |